TPIT tumors overexpressed neuronantin, which is silenced by promotor hypermethylation in PitNETs [39] and also MERTK, a receptor tyrosine kinase overexpressed in a variety of neoplasm and a potential therapeutic target [10]. The gene discussed is NTRK1; the disease is neoplasm.